Prolonged Exposure Therapy for PTSD Effective Even in Compressed Format

MONDAY, Jan. 9, 2023 (HealthDay News) -- Both massed and intensive outpatient forms of prolonged exposure (PE) therapy are fast and effective for combat-related posttraumatic stress disorder (PTSD), according to a study published online Jan. 5 in JAMA Network Open.
Alan L. Peterson, Ph.D., from University of Texas Health Science Center at San Antonio, and colleagues randomly assigned 234 military personnel and veterans to massed-PE (15 therapy sessions of 90 minutes each over three weeks) or intensive outpatient program PE (IOP-PE; 15 full-day therapy sessions over three weeks with eight treatment augmentations).
The researchers found that Clinician-Administered PTSD Scale scores decreased in both treatment groups at the one-month follow-up. During six-month follow-up, PTSD symptoms increased in massed-PE participants, while IOP-PE participants maintained treatment gains. PTSD Checklist scores decreased in both groups from baseline to one-month follow-up and were maintained at six months. Posttreatment, both groups had notable PTSD diagnostic remission (IOP-PE: 48 percent; massed-PE: 62 percent), which was maintained at six months (IOP-PE: 53 percent; massed-PE: 52 percent).
"The compressed treatment formats evaluated in this study also provide a potential for new alternative modes of therapy using combined treatments, medications, and devices," the authors write.
Related Posts
Serum Copeptin, Urinary AQP2 Lower in Children With Nocturnal Enuresis
THURSDAY, Aug. 3, 2023 (HealthDay News) -- Serum copeptin and urinary...
Los refuerzos de las vacunas contra la COVID son esenciales para algunos pacientes con cáncer: estudio
JUEVES, 24 de agosto de 2023 (HealthDay News) -- Los pacientes con cáncer con...
Eating Lots of ‘Ultra-Processed’ Foods Could Harm Your Brain
TUESDAY, Dec. 6, 2022 (HealthDay News) -- Chips, pizza, cookies: Delicious, but...
¿Quiere dejar de beber café, pero le da miedo la abstinencia? Pruebe con el descafeinado
VIERNES, 17 de febrero de 2023 (HealthDay News) -- Los investigadores quizá...